SE0203825D0 - Novel fused heterocycles and uses thereof - Google Patents

Novel fused heterocycles and uses thereof

Info

Publication number
SE0203825D0
SE0203825D0 SE0203825A SE0203825A SE0203825D0 SE 0203825 D0 SE0203825 D0 SE 0203825D0 SE 0203825 A SE0203825 A SE 0203825A SE 0203825 A SE0203825 A SE 0203825A SE 0203825 D0 SE0203825 D0 SE 0203825D0
Authority
SE
Sweden
Prior art keywords
fused heterocycles
novel fused
novel compounds
novel
heterocycles
Prior art date
Application number
SE0203825A
Other languages
English (en)
Inventor
Marshall Moringstar
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0203825A priority Critical patent/SE0203825D0/sv
Publication of SE0203825D0 publication Critical patent/SE0203825D0/sv
Priority to ES03781250T priority patent/ES2278211T3/es
Priority to DE60310767T priority patent/DE60310767T2/de
Priority to JP2004562221A priority patent/JP2006512366A/ja
Priority to EP03781250A priority patent/EP1585748B1/en
Priority to US10/539,936 priority patent/US20070004761A1/en
Priority to PCT/SE2003/002033 priority patent/WO2004056831A1/en
Priority to AU2003288869A priority patent/AU2003288869A1/en
Priority to AT03781250T priority patent/ATE349448T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE0203825A 2002-12-20 2002-12-20 Novel fused heterocycles and uses thereof SE0203825D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0203825A SE0203825D0 (sv) 2002-12-20 2002-12-20 Novel fused heterocycles and uses thereof
ES03781250T ES2278211T3 (es) 2002-12-20 2003-12-19 Derivados de pirazolo 3,4-d pirimidina y su uso en el tratamiento de infeccion por h. pylori.
DE60310767T DE60310767T2 (de) 2002-12-20 2003-12-19 PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
JP2004562221A JP2006512366A (ja) 2002-12-20 2003-12-19 ピラゾロ［３，４−ｄ］ピリミジン誘導体及び処置におけるその使用
EP03781250A EP1585748B1 (en) 2002-12-20 2003-12-19 PYRAZOLO 3,4-d PYRIMIDINE DERIVATIVES AND THEIR USE I N THE TREATMENT OF H.PYLORI INFECTION
US10/539,936 US20070004761A1 (en) 2002-12-20 2003-12-19 Pyrazolo [3,4-d] pyrimidine derivatives and their use in the treatment of h.pylori infection
PCT/SE2003/002033 WO2004056831A1 (en) 2002-12-20 2003-12-19 PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION
AU2003288869A AU2003288869A1 (en) 2002-12-20 2003-12-19 PYRAZOLO (3,4-d) PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION
AT03781250T ATE349448T1 (de) 2002-12-20 2003-12-19 Pyrazol-3,4-d-pyrimidinderivate und ihre verwendung bei der behandlung von h.pylori- infektionen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0203825A SE0203825D0 (sv) 2002-12-20 2002-12-20 Novel fused heterocycles and uses thereof

Publications (1)

Publication Number Publication Date
SE0203825D0 true SE0203825D0 (sv) 2002-12-20

Family

ID=20289974

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0203825A SE0203825D0 (sv) 2002-12-20 2002-12-20 Novel fused heterocycles and uses thereof

Country Status (9)

Country Link
US (1) US20070004761A1 (sv)
EP (1) EP1585748B1 (sv)
JP (1) JP2006512366A (sv)
AT (1) ATE349448T1 (sv)
AU (1) AU2003288869A1 (sv)
DE (1) DE60310767T2 (sv)
ES (1) ES2278211T3 (sv)
SE (1) SE0203825D0 (sv)
WO (1) WO2004056831A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005511500A (ja) 2001-08-31 2005-04-28 ザ ロックフェラー ユニバーシティー 脳におけるホスホジエステラーゼ活性およびホスホジエステラーゼ１ｂ媒介シグナル伝達の調節
WO2007143705A2 (en) 2006-06-06 2007-12-13 Intra-Cellular Therapies, Inc. Organic compounds
US9198924B2 (en) 2006-11-13 2015-12-01 Intra-Cellular Therapies, Inc. Organic compounds
JP5701608B2 (ja) 2007-12-06 2015-04-15 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
US8008327B2 (en) * 2008-04-29 2011-08-30 Boehringer Ingelheim International Gmbh Indazole compounds as CCR1 receptor antagonists
WO2009137338A1 (en) * 2008-05-06 2009-11-12 Boehringer Ingelheim International Gmbh Pyrazole compounds as ccr1 antagonists
PE20110854A1 (es) 2008-09-26 2011-12-23 Boehringer Ingelheim Int DERIVADOS DE 1-FENIL-1H-PIRAZOLO[3,4-c]PIRIDINA-4-CARBONILAMINA COMO ANTAGONISTAS DE LOS RECEPTORES CCR1
AU2009322905A1 (en) * 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
SG171777A1 (en) 2008-12-06 2011-07-28 Intra Cellular Therapies Inc Organic compounds
CN102238873A (zh) 2008-12-06 2011-11-09 细胞内治疗公司 有机化合物
SG178279A1 (en) 2009-08-05 2012-03-29 Intra Cellular Therapies Inc Novel regulatory proteins and inhibitors
KR20120087923A (ko) 2009-10-21 2012-08-07 베링거 인겔하임 인터내셔날 게엠베하 Ｃｃｒ１ 수용체 길항제로서의 인다졸 및 피라졸로피리딘 화합물
EP2493875B1 (en) 2009-10-27 2014-08-06 Boehringer Ingelheim International GmbH Heterocyclic compounds as ccr1 receptor antagonists
CA2782384A1 (en) * 2009-12-08 2011-06-16 Boehringer Ingelheim International Gmbh Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds
JP5793182B2 (ja) 2010-04-30 2015-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ１受容体アンタゴニストとしてのアザインダゾールアミド化合物
WO2011153135A1 (en) 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
WO2011153136A1 (en) 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
WO2012087782A1 (en) 2010-12-23 2012-06-28 Boehringer Ingelheim International Gmbh Pyrazolopiperidine compounds as ccr1 receptor antagonists
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
US11786528B2 (en) 2018-06-04 2023-10-17 Exscientia Ltd. Pyrazolopyrimidine compounds as adenosine receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839839A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen
SE0102315D0 (sv) * 2001-06-28 2001-06-28 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
JP2006512366A (ja) 2006-04-13
ES2278211T3 (es) 2007-08-01
DE60310767D1 (de) 2007-02-08
WO2004056831A1 (en) 2004-07-08
ATE349448T1 (de) 2007-01-15
AU2003288869A1 (en) 2004-07-14
US20070004761A1 (en) 2007-01-04
DE60310767T2 (de) 2007-10-11
EP1585748A1 (en) 2005-10-19
EP1585748B1 (en) 2006-12-27

Similar Documents

Publication Publication Date Title
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
SE0102315D0 (sv) Compounds
ATE423122T1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
MXPA05009885A (es) Nuevas triazolonas fusionadas y los usos de las mismas.
DE60225040D1 (de) Montelukast-granulatformulierung
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
DK1200418T3 (da) Nematodicide trifluorbutener
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
MY141233A (en) Enantiomers of selected fused heterocyclics and uses thereof
ECSP055844A (es) Nuevos compuestos triciclicos
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
MX2007001954A (es) Heterociclicos fusionados seleccionados y sus usos.
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
MY141583A (en) Novel fused heterocycles and uses thereof
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
SE0004101D0 (sv) New use
ATE301933T1 (de) Akarizidpulver
DK1523985T3 (da) Ikke-radioaktivt strontiumholdigt middel til behandling af kræft